|
|
|||
|
||||
OverviewEveryone expects something from the drug industry. Physicians and patients, investors, regulators and administrators all have an active interest. Everyone wants to know what makes drugs ‘work’ medically and economically. Why are drugs so expensive? Is it the drug companies or investors who demand high profits? What governs the pharmacoeconomics? Why are so few diseases treatable? Drug Discovery opens the windows and doors of the industry telling the story of drug development by using real stories from inside the process. Full Product DetailsAuthor: Tamas Bartfai (PhD, The Scripps Research Institute, La Jolla, CA<br>Harold L. Dorris Neurological Research Center and Scripps Research Institute, La Jolla, California, USA) , Graham V. Lees (PhD, Publishing Consultant, Corpus Alienum Oy, Finland)Publisher: Elsevier Science Publishing Co Inc Imprint: Academic Press Inc Dimensions: Width: 15.20cm , Height: 1.40cm , Length: 22.90cm Weight: 0.520kg ISBN: 9780123695338ISBN 10: 0123695333 Pages: 328 Publication Date: 06 January 2006 Audience: Professional and scholarly , Professional & Vocational Replaced By: 9780128192085 Format: Paperback Publisher's Status: Active Availability: In Print This item will be ordered in for you from one of our suppliers. Upon receipt, we will promptly dispatch it out to you. For in store availability, please contact us. Table of ContentsSection Headings: Introduction Part I. Medicine for Society Part II. From Basics to Bedside Part III. The Business of Making & Selling Legal Drugs Part IV. What Will Matter in Making Medicines?ReviewsDoody's 3 Star Review: It was refreshing reading about these matters from a different perspective. The critical nature of the book, I would imagine, was intentional to play the proverbial devil's advocate . This book truly caused me to rethink some attitudes and opinions I have had about pharmaceutical company behavior in the marketplace. It's nice that once in a while such a refreshing publication comes along. - Albert Wertheimer, B.S., MBA, PhD, Temple University School of Pharmacy for DOODY'S [This book] is very readable and insightful. I am hopeful that many people will pick it up, and develop a better appreciation for what goes into making the treatments that everyone wants! - Dennis W. Choi, M.D., Sr. VP Merck (2006) Anyone who thinks solutions to drug development are just around the corner would be well-advised to get this insider's views as to where the real problems lie. - Floyd Bloom, CEO Neurome, former Editor of Science magazine (2006) ...a very informative and exciting book filling an important niche. Very easy to read, it encouraged me to think about several things. - Richard Nass, Vanderbilt University (2006) """Doody's 3 Star Review: It was refreshing reading about these matters from a different perspective. The critical nature of the book, I would imagine, was intentional to play the proverbial ""devil's advocate"". This book truly caused me to rethink some attitudes and opinions I have had about pharmaceutical company behavior in the marketplace. It's nice that once in a while such a refreshing publication comes along."" - Albert Wertheimer, B.S., MBA, PhD, Temple University School of Pharmacy for DOODY'S ""[This book] is very readable and insightful. I am hopeful that many people will pick it up, and develop a better appreciation for what goes into making the treatments that everyone wants!"" - Dennis W. Choi, M.D., Sr. VP Merck (2006) ""Anyone who thinks solutions to drug development are just around the corner would be well-advised to get this insider's views as to where the real problems lie."" - Floyd Bloom, CEO Neurome, former Editor of Science magazine (2006) ""...a very informative and exciting book filling an important niche. Very easy to read, it encouraged me to think about several things."" - Richard Nass, Vanderbilt University (2006)" Doody's 3 Star Review: It was refreshing reading about these matters from a different perspective. The critical nature of the book, I would imagine, was intentional to play the proverbial devil's advocate . This book truly caused me to rethink some attitudes and opinions I have had about pharmaceutical company behavior in the marketplace. It's nice that once in a while such a refreshing publication comes along. - Albert Wertheimer, B.S., MBA, PhD, Temple University School of Pharmacy for DOODY'S [This book] is very readable and insightful. I am hopeful that many people will pick it up, and develop a better appreciation for what goes into making the treatments that everyone wants! - Dennis W. Choi, M.D., Sr. VP Merck (2006) Anyone who thinks solutions to drug development are just around the corner would be well-advised to get this insider's views as to where the real problems lie. - Floyd Bloom, CEO Neurome, former Editor of Science magazine (2006) ...a very informative and exciting book filling an important niche. Very easy to read, it encouraged me to think about several things. - Richard Nass, Vanderbilt University (2006) Author InformationFounding Editor, TheScientificWorld, CEO, Corpus Alienum Oy, Finland Tab Content 6Author Website:Countries AvailableAll regions |